- Home
- TEVA vs ZBH Comparison
TEVA vs ZBH Comparison
Compare TEVA & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- ZBH
- Stock Information
- Founded
- TEVA 1901
- ZBH 1927
- Country
- TEVA Israel
- ZBH United States
- Employees
- TEVA N/A
- ZBH N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- ZBH Industrial Specialties
- Sector
- TEVA Health Care
- ZBH Health Care
- Exchange
- TEVA Nasdaq
- ZBH Nasdaq
- Market Cap
- TEVA 21.2B
- ZBH 20.0B
- IPO Year
- TEVA N/A
- ZBH N/A
- Fundamental
- Price
- TEVA $18.39
- ZBH $99.90
- Analyst Decision
- TEVA Strong Buy
- ZBH Buy
- Analyst Count
- TEVA 7
- ZBH 18
- Target Price
- TEVA $24.71
- ZBH $112.00
- AVG Volume (30 Days)
- TEVA 10.3M
- ZBH 1.2M
- Earning Date
- TEVA 11-05-2025
- ZBH 10-29-2025
- Dividend Yield
- TEVA N/A
- ZBH 0.96%
- EPS Growth
- TEVA N/A
- ZBH N/A
- EPS
- TEVA N/A
- ZBH 4.11
- Revenue
- TEVA $16,628,000,000.00
- ZBH $7,833,800,000.00
- Revenue This Year
- TEVA $4.07
- ZBH $8.20
- Revenue Next Year
- TEVA $0.81
- ZBH $5.93
- P/E Ratio
- TEVA N/A
- ZBH $24.39
- Revenue Growth
- TEVA 2.08
- ZBH 4.11
- 52 Week Low
- TEVA $12.47
- ZBH $89.22
- 52 Week High
- TEVA $22.80
- ZBH $114.72
- Technical
- Relative Strength Index (RSI)
- TEVA 49.75
- ZBH 42.77
- Support Level
- TEVA $18.46
- ZBH $98.67
- Resistance Level
- TEVA $19.98
- ZBH $104.49
- Average True Range (ATR)
- TEVA 0.50
- ZBH 1.83
- MACD
- TEVA -0.10
- ZBH -1.03
- Stochastic Oscillator
- TEVA 23.68
- ZBH 15.53
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.